Greenbrook TMS Withdraws Public Offering of Common Shares
TORONTO--(BUSINESS WIRE)--Jun 25, 2021--
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“ Greenbrook ” or the “ Company ”) today announced that it has elected to withdraw its previously announced public offering of common shares (the “ Offering ”). In light of market conditions existing at the time the Offering was commenced, and the subsequent completion of the Company’s previously announced US$23.5 million private placement pursuant to Rule 506(c) under the U.S. Securities Act of 1933, the Company has determined to withdraw its short form base PREP prospectus in Canada and its registration statement on Form F-10 in the United States and, accordingly, will not be proceeding with the Offering.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
About Greenbrook TMS Inc.
Operating through 129 Company-operated treatment centers, Greenbrook is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 620,000 TMS treatments to over 17,000 patients struggling with depression.
Cautionary Note Regarding Forward-Looking Information
Certain information in this press release may constitute forward-looking information within the meaning of applicable securities laws in Canada and the United States, including the United States Private Securities Litigation Reform Act of 1995. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events.
Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in greater detail in the “Risk Factors” section of the Company’s current annual information form and in the Company’s other materials filed with the Canadian securities regulatory authorities and the SEC from time to time, available at www.sedar.com and www.sec.gov, respectively. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210625005484/en/
CONTACT: Glen Akselrod
Greenbrook TMS Inc.
KEYWORD: NORTH AMERICA CANADA
INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH MENTAL HEALTH MEDICAL DEVICES HEALTH
SOURCE: Greenbrook TMS Inc.
Copyright Business Wire 2021.
PUB: 06/25/2021 05:15 PM/DISC: 06/25/2021 05:17 PM